Vimarsana
Biggest News Aggregation in the World

Page 2 - Long Wu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Long Wu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Long Wu Today - Breaking & Trending Today

Advancing Global Health Equity & Harmonization - Vimarsana News

Advancing Global Health Equity & Harmonization

Join us for the first annual Cure4Cancer conference focused on advancing global health equity and harmonization.

Osimertinib Plus Chemo Ups PFS, Toxicity in First Line - Vimarsana News

Osimertinib Plus Chemo Ups PFS, Toxicity in First Line

Combining osimertinib with chemotherapy improved progression-free survival in EGFR-mutated non-small cell lung cancer, new interim data show, but experts have raised concerns about toxicity.

Adding First-Line Chemo Boosts PFS in EGFR-Mutant Lung Cancer - Vimarsana News

Adding First-Line Chemo Boosts PFS in EGFR-Mutant Lung Cancer

Osimertinib plus chemotherapy improved PFS by nearly 9 months versus targeted agent alone

ASCO 2023: Solid Tumors - Vimarsana News

ASCO 2023: Solid Tumors

Coverage of clinical trial results presented across a range of solid tumor cancers, including breast, ovarian, colorectal, and non-small cell lung cancer, among other types; as well as important findings in genomic testing.

Source: ajmc.com
Zorifertinib May Fulfill Unmet Need in EGFR-Mutant NSCLC With CNS Metastasis - Vimarsana News

Zorifertinib May Fulfill Unmet Need in EGFR-Mutant NSCLC With CNS Metastasis

Zorifertinib improves PFS when compared to gefitinib or erlotinib as first-line treatment for EGFR-mutant NSCLC with CNS metastases.